Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth

Amgen (AMGN) reported first-quarter 2025 adjusted earnings of $4.90 per share, which beat the Zacks Consensus Estimate of$4.16 per share. Earnings rose 24% year over year as higher revenues were partially offset by higher operating costs.Total revenues of $8.1 billion also beat the Zacks Consensus Estimate of$7.95 billion. Total revenues rose 9% year over year.Total product revenues increased 11% from the year-ago quarter to $7.87 billion as volume growth was partially offset by continued price declines. ...